Results 211 to 220 of about 45,519 (269)
Effects of Phagocytosis and Colchicine on the Distribution of Lectin-Binding Sites on Cell Surfaces
Janet M. Oliver, T. E. Ukena, R D Berlin
openalex +1 more source
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source
Colchicine in Patients with Chronic Coronary Disease
BACKGROUND Evidence from a recent trial has shown that the antiinflammatory effects of colchicine reduce the risk of cardiovascular events in patients with recent myocardial infarction, but evidence of such a risk reduction in patients with chronic ...
Arend Mosterd +2 more
exaly +2 more sources
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
BACKGROUND Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.
Jean-Claude Tardif +2 more
exaly +2 more sources
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
It is over 50 years since the discovery of microtubules, and they have become one of the most important drug targets for anti-cancer therapies. Microtubules are predominantly composed of the protein tubulin, which contains a number of different binding ...
Eavan C Mcloughlin, Niamh M O'boyle
exaly +2 more sources
Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation
Jui-Hsia Weng +2 more
exaly +2 more sources

